ISAAC MINEHART: Open Payments
NPI 1639167091 · ARCADIA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$882 in 23 payments from 7 companies in 2025. Trend: 2023 $1,220 · 2024 $700 · 2025 $882
Food & beverage: $882
| Company | Payments | Amount |
|---|---|---|
| Boston Scientific Corporation | 4 | $329 |
| PROTEGA PHARMACEUTIALS INC | 10 | $160 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $124 |
| Kowa Pharmaceuticals America, Inc. | 1 | $122 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $94 |
| VERTEX PHARMACEUTICALS INCORPORATED | 2 | $35 |
| ABBVIE INC. | 1 | $19 |
Products named: Intracept, ROXYBOND, CAPLYTA, ZORYVE, RELISTOR, JOURNAVX, UBRELVY.
Industry payments across CA — which companies pay providers there.
